在第19届国际心室动脉缩研讨会上, 导管精度将介绍其FDA批准的VIVO 3D成像工具的数据. Catheter Precision to present data on its FDA-cleared VIVO 3D imaging tool at the 19th annual International Ventricular Tachycardia Symposium.

Catheter Precision， Inc. 将于 10 月 11 日至 12 日参加在纽约市举行的第 19 届年度国际室性心动过速研讨会。 Catheter Precision, Inc. will attend the 19th annual International Ventricular Tachycardia Symposium on October 11-12 in New York City. 活动内容将包括心血管心律失常的管理战略。 The event will cover management strategies for ventricular arrhythmias. 该公司计划提供其VIVOTM系统的数据,VIVOTM系统是一个非侵入性的三维成像工具,有助于在程序前查明心律不全的起源。 The company plans to present data on its VIVO™ system, a non-invasive 3D imaging tool that aids in identifying arrhythmia origins before procedures. 维沃已获得FDA的营销许可和CE标志. VIVO has received FDA marketing clearance and CE marking.